mTOR and cancer: insights into a complex relationship

@article{Sabatini2006mTORAC,
  title={mTOR and cancer: insights into a complex relationship},
  author={David M. Sabatini},
  journal={Nature Reviews Cancer},
  year={2006},
  volume={6},
  pages={729-734}
}
mTOR (mammalian target of rapamycin) has come a long way since its humble beginnings as a kinase of unknown function. As part of the mTORC1 and mTORC2 complexes mTOR has key roles in several pathways that are involved in human cancer, stimulating interest in mTOR inhibitors and placing it on the radar of the pharmaceutical industry. Here, I discuss the rationale for the use of drugs that target mTOR, the unexpectedly complex mechanism of action of existing mTOR inhibitors and the potential… CONTINUE READING
Highly Influential
This paper has highly influenced 58 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 611 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 94 references

A pharmacological map of the PI 3Kfamily defines a role for p 110 α in insulin signaling

  • Z. A. Knight
  • Cell
  • 2006

Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus

  • D. Del Bufalo
  • Cancer Res .
  • 2006

Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma

  • M. Rudelius
  • Blood
  • 2006

Critical role for the p 110 α phosphoinositide3OH kinase in growth and metabolic regulation

  • L. C. Foukas
  • Nature
  • 2006

Hypoxia - inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer

  • G. V. Thomas
  • Nature Med .
  • 2006

Similar Papers

Loading similar papers…